Education, Research I 26 August 2024 WECAN’s Evidence-Based Advocacy Program: How Cancer Patient Advocates Ideated a Survey Where it all began: the workshop On January 17th-19th 2024, a group of 40 patient advocates, carers, and clinicians from 20 European countries have met in Munich, Germany, to participate in a workshop. Industry stakeholders
Statement I 26 August 2024 Are you a patient advocate or aspiring to be one? Become a WECAN Evidence-Based Advocacy group member! The WECAN Evidence-Based advocacy group is excited to announce the election of new members. To find more information about what the group does, click HERE or contact
Research I 7 March 2025 Phase 2 extension close to completion! In this phase, we updated details on the geographical distribution of clinical trials, the use of Patient-Reported Outcome Measures (PROMs), and trends in publishing Patient-Reported Outcomes (PROs). These findings enhance our understanding of clinical trial accessibility and highlight the importance of
Research I 7 March 2025 Advancing Research & Patient Advocacy with a Novel Methodology To generate knowledge, we had to create our own tools, and we hope they are useful for advocacy in other areas too! In collaboration with Syreon, we are proud to be pioneers in developing a novel methodology for
Capacity Building I 5 August 2024 Recap of the Transformative WECAN Academy 2024: Empowering Cancer Patient Advocates Worldwide 2024 WECAN Academy Booklet - Click here to download. This year, the WECAN Academy brought together close to 90 dedicated advocates from 32 countries for an immersive and transformative experience.